Ftse Mib
33.815,85
0,21%
DAX
17.950,69
0,16%
S&P 500
5.036,13
0,35%
NASDAQ Composite
15.728,66
0,79%
Bitcoin
58.458,79
0,38%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Acacia Pharma Group Plc (0PNT) Acacia Pharma Group Plc (0PNT) Notizie

0PNT

Acacia Pharma (0PNT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0PNT
DataOraFonteTitoloSimboloCompagnia
09/06/202213:00UK RegulatoryAcacia Pharma Group plc Scheme Of Arrangement Becoming EffectiveLSE:0PNTAcacia Pharma Group Plc
07/06/202213:00UK RegulatoryAcacia Pharma Group plc Court Sanction Of The Scheme Of ArrangementLSE:0PNTAcacia Pharma Group Plc
20/05/202208:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Results Of The Court Meeting And The General Meeting Held On 19 May 2022LSE:0PNTAcacia Pharma Group Plc
29/04/202223:02UK RegulatoryAcacia Pharma Group plc Publication Of Annual Report And Financial Statements For The Year Ended 31 December 2021LSE:0PNTAcacia Pharma Group Plc
27/04/202212:00UK RegulatoryAcacia Pharma Group plc Publication Of Scheme DocumentLSE:0PNTAcacia Pharma Group Plc
31/03/202218:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Group Plc - Total Number Of Voting Rights And CapitalLSE:0PNTAcacia Pharma Group Plc
30/03/202218:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma To Postpone Publication Of Its Results For The Full Year 2021, Scheduled On 31 March 2022LSE:0PNTAcacia Pharma Group Plc
28/03/202208:00UK RegulatoryAcacia Pharma Group plc Offer By Eagle Pharmaceuticals, Inc.LSE:0PNTAcacia Pharma Group Plc
23/03/202207:10UK RegulatoryAcacia Pharma Group plc Acacia Pharma Announces Chief Financial Officer Gary Gemignani Is To Leave The CompanyLSE:0PNTAcacia Pharma Group Plc
15/03/202218:07UK RegulatoryAcacia Pharma Group plc Issue Of Shares To Employee Benefit TrustLSE:0PNTAcacia Pharma Group Plc
21/12/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Issues Ordinary Shares To Its Employee Benefit TrustLSE:0PNTAcacia Pharma Group Plc
16/12/202112:18UK RegulatoryAcacia Pharma Group plc Correction: Issue Of Shares To Employee Benefit TrustLSE:0PNTAcacia Pharma Group Plc
13/12/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Announces Successful Completion Of Barhemsys(R) Post-approval Requirement Study In Patients With Severe Renal ImpairmentLSE:0PNTAcacia Pharma Group Plc
10/11/202113:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma To Present At The Jefferies London Healthcare ConferenceLSE:0PNTAcacia Pharma Group Plc
30/09/202107:00UK RegulatoryAcacia Pharma Group plc Interim Results For The Six Months Ended 30 June 2021 - Barhemsys(R) And Byfavo(R) Launches Continue To Achieve Strong Hospital Formulary AdoptionLSE:0PNTAcacia Pharma Group Plc
29/09/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Announces Submission And Validation Of Marketing Authorization Application For Barhemsys(R) (amisulpride injection) In Major European MarketsLSE:0PNTAcacia Pharma Group Plc
23/09/202113:10UK RegulatoryAcacia Pharma Group plc Correction: Notice Of ResultsLSE:0PNTAcacia Pharma Group Plc
23/09/202113:00UK RegulatoryAcacia Pharma Group plc Notice Of ResultsLSE:0PNTAcacia Pharma Group Plc
16/09/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Announces Initiation Of Pivotal Study Of Byfavo(R) In Pediatric Procedural SedationLSE:0PNTAcacia Pharma Group Plc
02/09/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma To Host Webinar With Key Opinion Leaders To Discuss The Hospital User Experience With Barhemsys(R) And Byfavo(R)LSE:0PNTAcacia Pharma Group Plc
05/07/202115:02UK RegulatoryAcacia Pharma Group plc Correction: Transparency Notification - Pdf Of Notification AttachedLSE:0PNTAcacia Pharma Group Plc
01/07/202108:00UK RegulatoryAcacia Pharma Group plc Transparency NotificationLSE:0PNTAcacia Pharma Group Plc
01/07/202107:00UK RegulatoryAcacia Pharma Group plc Significant Continued Progress With Formulary Uptake Of Barhemsys(R) And Byfavo(TM) In The UsLSE:0PNTAcacia Pharma Group Plc
29/06/202107:00UK RegulatoryAcacia Pharma Group plc Results Of Annual General MeetingLSE:0PNTAcacia Pharma Group Plc
25/05/202118:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Group Plc: Notice Of Annual General MeetingLSE:0PNTAcacia Pharma Group Plc
25/05/202112:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma To Participate In Jefferies Virtual Healthcare ConferenceLSE:0PNTAcacia Pharma Group Plc
19/05/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Appoints Debra Hussain As Chief Commercial OfficerLSE:0PNTAcacia Pharma Group Plc
04/05/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Announces Early Repayment Of Loan Facility From Hercules Technology Growth Capital And ...LSE:0PNTAcacia Pharma Group Plc
21/04/202107:00UK RegulatoryAcacia Pharma Group plc Acacia Pharma Becomes New Industry Supporter Of The American Society Of AnesthesiologistsLSE:0PNTAcacia Pharma Group Plc
30/03/202107:00UK RegulatoryAcacia Pharma Group plc Publication Of Annual Report 2020LSE:0PNTAcacia Pharma Group Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0PNT

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
AMP
Amplifon
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network